Prøve GULL - Gratis
"The ecosystem of Gujarat is ready to promote deep tech areas of biotech product development"
Bio Spectrum
|BioSpectrum Indian Feb 2025
ujarat has more than 200 biotechnology Gamers and a thriving startup ecosystem that includes prominent R&D and educational institutes. Gujarat's biotech sector generates more than Rs 12000 crore revenue and serves as an established biomanufacturing hub. Playing a key role in this direction is the Gujarat State Biotechnology Mission GSBTM) which has completed 20 years. The Government of Gujarat GoG) had established GSBTM in April 2004 under the Department of Science and Technology to facilitate the development of the biotech sector. In conversation with BioSpectrum, Manish Gurwani, Mission Director, Gujarat State Biotechnology Mission elaborates on how GSBTM’s latest biotechnology policy is transforming the sector in Gujarat. Edited excerpts:
How does the GSBTM plan to leverage infrastructure and incentives under the current policy to position the state as a globally competitive biotechnology hub?
Known for its entrepreneurship spirit, Gujarat has continued to be one of the preferred investment destinations for Ease of Doing Business (EoDB), Good Governance Index (GGI), Energy & Climate Index, Startup & LEADS ranking. The state contributes 40 per cent to India’s total cargo throughput with ~8.2 per cent in India’s GDP (as on FY2022-23 on current price). The state accounts for $12 billion (2023) with 8 per cent share of Bioeconomy, way above ~4 per cent state-wise average contribution of Bio-economy, amongst top 5 states of India in terms of Bio-economy contributors. This is the result of its top-class trunk and core infrastructure coupled with a safe and sound social environment in attracting top entrepreneurs from various parts of the country and abroad.
Gujarat showed great foresight, by setting up a dedicated mission office two decades ago, the Gujarat State Biotechnology Mission (GSBTM) followed by eco-system strengthening initiatives like Gujarat Biotechnology Research Centre (GBRC), Gujarat Biotechnology University (GBU) – Asia’s first ever dedicated biotechnology university and one of the top 5 public incubators Savli Technology and Business Incubator (STBI) with dedicated biotechnology parks for greenfield and brownfield spaces. These initiatives indicate Gujarat’s readiness to attract top biotech players in one of the thriving biotech ecosystems. GSBTM not only operates different schemes for facilitation of biotechnology, but is also the single window clearance office for all purposes, bringing in ease of doing business.
Denne historien er fra BioSpectrum Indian Feb 2025-utgaven av Bio Spectrum.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Bio Spectrum
Bio Spectrum
Thermo Fisher Scientific invests Rs 160 Cr+ to expand Bengaluru R&D facility
Thermo Fisher Scientific's expanded Research and Development (R&D) Centre of Excellence was inaugurated in Bengaluru by Sanjeev Kumar Gupta, CEO, Karnataka Digital Economy Mission (KDEM).
1 min
December 2025
Bio Spectrum
Motorica strengthens India presence with appointment of Kavinder Beniwal as COO
Motorica, a Delhi-based medtech company specialising in assistive technologies and medical cybernetics, has announced the appointment of Kavinder Beniwal as Chief Operational Officer (COO) of Motorica India.
1 min
December 2025
Bio Spectrum
Cabinet approves major expansion of PG and UG medical education capacity
Union Cabinet chaired by the Prime Minister Narendra Modi has approved the Phase-Ill of the Centrally Sponsored Scheme (CSS) for strengthening and upgradation of existing State Government/ Central Government Medical Colleges/Standalone PG Institutes/ Government Hospitals for increasing 5,000 PG seats and extension of the CSS for upgradation of existing government medical colleges for increasing 5,023 MBBS seats with an enhanced cost ceiling of Rs 1.5 crore per seat.
1 min
December 2025
Bio Spectrum
Dr Sharvil Patel steps in as Indian Pharmaceutical Alliance President
The Indian Pharmaceutical Alliance (IPA) has announced a leadership transition, with Dr Sharvil Patel, Managing Director of Zydus Lifesciences and former Vice President of IPA, assuming the role of President.
1 min
December 2025
Bio Spectrum
PAG-led Sekhmet Pharmaventures announces appointment of Mukesh Agarwal as CFO
Hyderabad-based Sekhmet Pharmaventures, a fast-emerging global API/CDMO player led by leading Asia-focused investment firm PAG, has announced the appointment of Mukesh Agarwal as its new Chief Financial Officer (CFO).
1 min
December 2025
Bio Spectrum
Monash University Malaysia and Tata Chemicals forge healthcare researchfocused partnership
The importance of gastrointestinal health is a key focus for researchers and innovators, as highlighted by the partnership between Monash University Malaysia and Tata Chemicals Limited.
1 min
December 2025
Bio Spectrum
"India has the talent and ambition to lead globally in advanced therapies, biologics, and oncology"
Thermo Fisher Scientific has recently announced plans to make significant investments in India's biopharma infrastructure, with new facilities that will enhance the biopharma manufacturing capabilities. Central to this expansion strategy are two major facilities in Genome Valley, Hyderabad, i.e. Bioprocess Design Center (BDC), and Customer Experience Center (CEC). In addition, the company has invested more than Rs 160 crore this year to expand its R&D facility in Bengaluru. For further understanding on these new developments, BioSpectrum spoke in detail to Srinath Venkatesh, Managing Director, India & South Asia, Thermo Fisher Scientific. Edited excerpts;
4 mins
December 2025
Bio Spectrum
"AI is a transformative enabler that's reshaping how science is conducted in labs"
2025 witnessed multiple new initiatives taken by Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, for the Indian market. These initiatives included establishment of an India Solutions Center in Manesar; and a Biopharma Experience Center in Hyderabad. 2025 also saw Nandakumar Kalathil stepping in as the new Country General Manager for Agilent India. With over 25 years of experience in the analytical industry, Nanda brings extensive expertise in leadership, team management, and customer relations. To find out more about the company's growth plans in 2026 in India, BioSpectrum interacted with Nandakumar Kalathil, Country General Manager for Agilent India in detail. Edited excerpts:
4 mins
December 2025
Bio Spectrum
Supporting India's Biopharma Expansion with Advanced, High-Performance Media
Kent Wang graduated from East China University of Science and Technology in Biochemical Engineering. He has over 12 years of experience in upstream biopharmaceutical process development, contributing to clinical projects including monoclonal antibodies, bispecific antibodies, and ADCs. He is well-versed in CHO cell metabolism and culture media characteristics, and has optimized critical quality attributes such as glycosylation, charge variants, fragmentation, aggregation, and amino acid oxidation. Previously at Shanghai Pharmaceuticals Group and 3S Bio, he now serves as Senior R&D Director at Duoning Biotech, focusing on serum-free cell culture media development. He established a comprehensive platform for media formulation and product development, leading his team to create a diverse portfolio of media for CHO, HEK293, insect, vaccine, hybridoma, and lymphocyte cell lines, leveraging cell metabolism insights and big data modeling.
4 mins
December 2025
Bio Spectrum
Corning and SGD Pharma inaugurate glass tubing facility in Telangana for pharma packaging
Corning Inc and SGD Pharma have announced the inauguration of a new glass tubing facility in Telangana, which will expand pharmaceutical manufacturing in the region.
1 min
December 2025
Listen
Translate
Change font size
